Trial record 1 of 1 for: NCT01782287
Previous Study | Return to List | Next Study
Proteome-based Immunotherapy of Lung Cancer Brain Metastases
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01782287|
Recruitment Status : Unknown
Verified October 2017 by NeuroVita Clinic.
Recruitment status was: Enrolling by invitation
First Posted : February 1, 2013
Last Update Posted : October 12, 2017
Blokhin's Russian Cancer Research Center
Russian Foundation of Technological Development
The Serbsky State Scientific Center for Social and Forensic Psychiatry
National Institute of Regenerative Medicine
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||December 2018|
|Estimated Study Completion Date :||December 2020|
Publications of Results:
Bryukhovetskiy IS, Mischenko PV, Tolok EV, Zaitcev SV, Khotimchenko YS, Bryukhovetskiy AS. Directional migration of adult hematopoeitic progenitors to C6 glioma in vitro. Oncol Lett. 2015 Apr;9(4):1839-1844. Epub 2015 Feb 10.
Bryukhovetskiy A, Shevchenko V, Kovalev S, Chekhonin V, Baklaushev V, Bryukhovetskiy I, Zhukova M. To the novel paradigm of proteome-based cell therapy of tumors: through comparative proteome mapping of tumor stem cells and tissue-specific stem cells of humans. Cell Transplant. 2014;23 Suppl 1:S151-70. doi: 10.3727/096368914X684907. Epub 2014 Oct 9.